AZN
AstraZeneca PLCStock · Health CareMSCI EAFE 1.4% · MSCI World 0.3% · MSCI ACWI 0.3% · Nasdaq Composite 0.0000%$168.10+1.22%
as of market close, Sep 21, 2026
☾ AH $168.10 +0.00%
AstraZeneca PLC returns by year
Through September 21, 2026
AstraZeneca PLC returns by year (2010–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $183.86 | $168.1 | +1.0% | -7.6% | |
| 2025 | $131.04 | $183.86 | +3.0% | +43.3% | |
| 2024 | $134.7 | $131.04 | +2.1% | -0.6% | |
| 2023 | $135.6 | $134.7 | +2.1% | +1.4% | |
| 2022 | $116.5 | $135.6 | +2.8% | +19.2% | |
| 2021 | $99.98 | $116.5 | +3.2% | +19.7% | |
| 2020 | $99.72 | $99.98 | +2.9% | +3.1% | |
| 2019 | $75.96 | $99.72 | +4.4% | +35.7% | |
| 2018 | $69.4 | $75.96 | +4.4% | +13.9% | |
| 2017 | $54.64 | $69.4 | +6.2% | +33.2% | |
| 2016 | $67.9 | $54.64 | +4.5% | -15.0% | |
| 2015 | $70.38 | $67.9 | +4.0% | +0.5% | |
| 2014 | $59.37 | $70.38 | +5.0% | +23.6% | |
| 2013 | $47.27 | $59.37 | +7.6% | +33.2% | |
| 2012 | $46.29 | $47.27 | +6.4% | +8.5% | |
| 2011 | $46.19 | $46.29 | +5.8% | +6.0% | |
| 2010 | $46.94 | $46.19 | +5.1% | +3.5% |
- Annualized
- +14.1%
- 2010–2026
- Average year
- +14.3%
- 16 full years
- Best year
- +43.3%
- 2025
- Worst year
- -15.0%
- 2016
- Positive years
- 14/16
- 88% up
Annualized (CAGR)
+14.1%
2010–2026
Average year
+14.3%
16 full years
Best year
+43.3%
2025
Worst year
-15.0%
2016
Positive years
14/16
88% up
Total return by period#
Annual
-40%-20%0%20%40%
2010+3.5%'10
2011+6.0%'11
2012+8.5%'12
2013+33%'13
2014+24%'14
2015+0.51%'15
2016-15%'16
2017+33%'17
2018+14%'18
2019+36%'19
2020+3.1%'20
2021+20%'21
2022+19%'22
2023+1.4%'23
2024-0.62%'24
2025+43%'25
2026-7.6%'26
Methodology#
Returns are total returns (dividends reinvested), computed from AZN's split- and dividend-adjusted closes. The bar chart switches between annual and monthly periods. Annualized return is the compound annual growth rate over the full period. The current year is year-to-date. Past performance does not predict future returns; not investment advice.
FAQ#
- What is AstraZeneca PLC's average annual return?
- Since 2010, AstraZeneca PLC (AZN) has returned about 14.1% a year (the compound annual growth rate) and an average calendar-year return of 14.3%.
- What were AstraZeneca PLC's best and worst years?
- Over 2010–2026, the best year was 2025 (+43.3%) and the worst was 2016 (-15.0%).
- How often is AstraZeneca PLC up in a year?
- 14 of the 16 full years since 2010 were positive — about 88% of the time.
More on AstraZeneca PLC
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100